Ramathibodi Hospital, Mahidol University
Mahidol's second great teaching hospital, with leading Thai programmes in paediatric oncology, haematology, cancer genetics and hepatobiliary surgery.
Ramathibodi Hospital opened in 1969 as Mahidol University's second faculty of medicine and is one of Thailand's top research hospitals. It is known for paediatric haematology-oncology and thalassaemia, adult haematology and stem cell transplant, the Ramathibodi cancer genetics and pharmacogenomics programmes, hepatobiliary and colorectal surgery, and a large radiation oncology service; it also participates widely in international trials in breast, lung and gastrointestinal cancer. The Chakri Naruebodindra Medical Institute campus and the Ramathibodi Comprehensive Cancer Center expand its capacity, and Mahidol's Institute of Molecular Biosciences supports cholangiocarcinoma and liver-fluke research relevant to north-east Thailand.
- Paediatric oncology
- Haematology and transplant
- Cancer genetics and pharmacogenomics
- Comprehensive Cancer Center
Pages like this
not linked directly; found by shared links- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionHospital Universitari i Politècnic La Fe
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionKing Hussein Cancer Center
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTawam Hospital
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- TargetCD7
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.